RE:Looked at Q3 filing on Sedar againN0taP00p ... Calm down. And stop trying to come with all sorts of negative scenarios. You've often been wrong in the past.
TLT management brought us here, on a shoestring budget and have always solve issues. TLT is no different than any other SMB or biotechs; it has to manage the burn rate. And if you understand the micro and macro environment of biotechs, you'll admit that financing has not been obvious for any of them in the last 3y.
I know you graduated from Bungee's kindergarten with FGPstuck with your "respect the shareholders" mantra but we all know what are the next steps for this company. But you're asking for info. that you wouldn't even divulge yourself if you were at the head of a competitive smb. So just grow on the maturity side as TLT management is competent enough to know what they have to do to get us there. You, not so much. Playing the armchair quarterback like you do is so easy.